STOCK TITAN

Columbia Financial, Inc./MD/ (CLBK) SEC Filings, Sep-Oct 2026

CLBK NASDAQ

Columbia Financial, Inc. filings document material events for the holding company of Columbia Bank, including furnished earnings releases, Regulation FD presentation materials, governance updates and capital-structure disclosures. Recent 8-K filings record operating and financial results, executive appointments, officer-designation matters and board succession disclosures involving the company and its wholly owned bank subsidiary.

The filing record also covers shareholder voting matters, material agreements and corporate-governance items that relate to Columbia Financial’s public-company reporting obligations. These disclosures connect the company’s banking operations with formal records on financial performance, management responsibilities, board composition and securities-related actions.

Rhea-AI Summary

Columbia Financial, Inc. reported that John Klimowich, SEVP & Chief Risk Officer, acquired 64.1631 phantom-stock units through the Columbia Bank Stock Based Deferral Plan on October 16, 2026. The transaction lists $10.67 per share, and 20,852.5772 units were held through the plan afterward. The Bank’s rabbi-trust trustee purchases the phantom stock on a non-discretionary basis; plan interests are settled in shares upon distribution to Klimowich.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.76%
Tags
insider
-
Rhea-AI Summary

Columbia Financial, Inc. President & CEO Thomas J. Kemly reported an acquisition of 163 shares through the Columbia Bank Stock-Based Deferral Plan on October 2, 2026, at $11.4100 per share. His reported resulting position through the plan was 154,960 shares. The phantom stock is purchased non-discretionarily by the Bank’s rabbi-trust trustee, and plan interests settle in shares upon distribution.

As of October 2, 2026, Kemly also reported direct stock options over 1,444,236 common shares with a $7.1000 exercise price, expiring July 23, 2029, along with four other option tranches.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.77%
Tags
insider
-
Rhea-AI Summary

Columbia Financial, Inc. (symbol: CLBK) is the issuer of record for a Form 4 filing submitted to the SEC. On October 2, 2026, a trustee of the Bank's rabbi trust purchased 14.9361 phantom stock units on a non-discretionary basis for Noel R. Holland, a director. The reported Stock-Based Deferral Plan holding afterward was 29,847.4821 units, which are settled in shares upon distribution. Holland also directly held 80,797 common shares and 183,246 shares underlying fully vested and exercisable options, with a $7.1000 exercise price and July 23, 2029 expiration.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.77%
Tags
insider
Rhea-AI Summary

Columbia Financial, Inc. (CLBK) SEVP & Chief Risk Officer John Klimowich reported acquiring 60 stock units on October 2, 2026, held indirectly through the Columbia Bank Stock Based Deferral Plan. The trustee purchased the phantom stock on a non-discretionary basis at $11.4100 per share; the plan’s stock-unit interests are settled in shares upon distribution. The reported post-transaction position through the plan was 20,788 shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.77%
Tags
insider
-
Rhea-AI Summary

Columbia Financial, Inc. (CLBK) reported that SEVP & Chief Risk Officer John Klimowich acquired 59.1208 shares of Common Stock on September 18, 2026, as a grant under the Columbia Bank Stock Based Deferral Plan at $11.58 per share, held indirectly through a stock-based deferral plan. Following this grant, he holds 20,728.4124 shares in that deferral plan and additional Common Stock through direct holdings, a 401(k), an ESOP, SERP, and several stock award vehicles. He also holds multiple stock option positions on CLBK shares with exercise prices between $7.10 and $8.31, and no Rule 10b5-1 trading plan is reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.90%
Tags
insider
-
Rhea-AI Summary

Columbia Financial, Inc. (CLBK) reported that President and CEO Thomas J. Kemly acquired additional common stock-equivalent interests on September 18, 2026 through a stock-based deferral arrangement. He received 160.4222 units of phantom stock, valued at $11.58 per unit, credited on a non‑discretionary basis to a rabbi trust under the Columbia Bank Stock Based Deferral Plan, a non-qualified stock-based deferral plan. Following this award, his interest in that deferral plan totals 154,796.7866 stock units, which will be settled in shares of common stock upon distribution. The filing also lists substantial existing direct and indirect holdings of Columbia Financial common stock and several series of stock options granted under the 2019 Equity Incentive Plan, with exercise prices between $7.10 and $8.31 and expirations from 2029 to 2036. No Rule 10b5-1 trading plan is reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.90%
Tags
insider
Rhea-AI Summary

Columbia Financial, Inc. (CLBK) reported that SEVP & Chief Risk Officer John Klimowich acquired 58.5145 shares of common-stock-equivalent phantom stock on September 4, 2026 at $11.70 per share through the Columbia Bank Stock Based Deferral Plan, held in a rabbi trust and to be settled in shares upon distribution.

After this award, his indirect deferral-plan balance is 20,669.292 shares, alongside substantial vested and unvested stock options with exercise prices between $7.10 and $8.31, and additional direct and indirect common stock holdings in retirement and stock award programs; no Rule 10b5-1 trading plan is reported for this transaction.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.29%
Tags
insider
-
Rhea-AI Summary

Columbia Financial, Inc. (CLBK) reports that President & CEO Thomas J. Kemly received an award of about 159 shares of Common Stock on September 4, 2026 at $11.70 per share, credited as phantom stock under the Columbia Bank Stock Based Deferral Plan and held indirectly through a rabbi trust. Following this award, he indirectly holds about 154,636 share-equivalent units in that plan, plus substantial direct and indirect Common Stock holdings and multiple stock option grants with exercise prices between $7.10 and $8.31 per share. No Rule 10b5-1 trading plan is reported and no open-market purchases or sales are shown.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.29%
Tags
insider
-
Rhea-AI Summary

Columbia Financial, Inc. (symbol: CLBK) is the issuer of record for a Form 4 filing submitted to the SEC.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.29%
Tags
insider
Rhea-AI Summary

Columbia Financial, Inc. (CLBK) director Noel R. Holland reported activity in the company’s common stock on September 3, 2026. He purchased 20 shares in an open-market or private transaction at $11.68 per share and on the same day made a bona fide gift of 20 shares, resulting in no net change in his share count from these two transactions.

He continues to hold stock options giving the right to acquire 183,246 shares of common stock at an exercise price of $7.10 per share, expiring July 23, 2029; these options are fully vested and exercisable. Indirect holdings include 29,817.9802 shares through a stock-based deferral plan, 109,316 shares through a SEP-IRA, and 6,494 shares through stock awards under the 2019 Equity Incentive Plan that vest in one year on March 12, 2027. No transactions are reported as having been made under a Rule 10b5-1 trading plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.00%
Tags
insider

FAQ

How many Columbia Financial, Inc./MD/ (CLBK) SEC filings are available on StockTitan?

StockTitan tracks 51 SEC filings for Columbia Financial, Inc./MD/ (CLBK), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Columbia Financial, Inc./MD/ (CLBK)?

The most recent SEC filing for Columbia Financial, Inc./MD/ (CLBK) was filed on November 17, 2026.